This inventor holds 1 USPTO granted patent. Top assignee: Scripps Research Institute. Active years: 2008.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2008
Title: The Innovations of Chi-Heuy Wong
Introduction
Chi-Heuy Wong is an accomplished inventor based in Rancho Santa Fe, CA (US). He has made significant contributions to the field of biochemistry, particularly in the area of glycoprotein synthesis. His innovative work has led to the development of methods that enhance the incorporation of specific amino acids into proteins.
Latest Patents
Wong holds a patent titled "In vivo site-specific incorporation of N-acetyl-galactosamine amino acids in eubacteria." This patent outlines methods and compositions for making glycoproteins, both in vitro and in vivo. One of the key methods described involves incorporating an unnatural amino acid that contains a N-acetylgalactosamine moiety into a protein. Additionally, this unnatural amino acid can be further modified with additional sugars, showcasing Wong's innovative approach to protein engineering.
Career Highlights
Chi-Heuy Wong is affiliated with the Scripps Research Institute, where he continues to push the boundaries of scientific research. His work has garnered attention for its potential applications in therapeutic development and biotechnology. Wong's dedication to advancing the field of biochemistry is evident through his research and patent contributions.
Collaborations
Wong has collaborated with notable scientists such as Sarah R. Hanson and Peter G. Schultz. These partnerships have fostered a collaborative environment that enhances the research output and innovation within the Scripps Research Institute.
Conclusion
Chi-Heuy Wong's contributions to the field of biochemistry, particularly through his patent on glycoprotein synthesis, highlight his role as a leading inventor. His work not only advances scientific knowledge but also opens new avenues for therapeutic applications.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
